Paul S Covington's Net Worth
$12.5 Million
Who is Paul S Covington?
Paul S Covington has an estimated net worth of $12.5 Million. This is based on reported shares across multiple companies, which include Furiex Pharmaceuticals, Inc., and PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
SEC CIK
Paul S Covington's CIK is 0001181153
Past Insider Trading and Trends
2005 was Paul S Covington's most active year for acquiring shares with 7 total transactions. Paul S Covington's most active month to acquire stocks was the month of January. 2008 was Paul S Covington's most active year for disposing of shares, totalling 55 transactions. Paul S Covington's most active month to dispose stocks was the month of January. 2008 saw Paul S Covington paying a total of $1,811,248.53 for 62,285 shares, this is the most they've acquired in one year. In 2014 Paul S Covington cashed out on 204,685 shares for a total of $6,473,422.53, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Furiex Pharmaceuticals, Inc. No price found
Senior VP-Clinical OperationsPaul S Covington used to own units in Common Stock but no longer holds any shares there. In the year 2010 Paul S Covington filed a total of 14 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.52K |
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
$60.96 | -$894,965.76 | 22.52K |
Jun 24
| |||
Form 4
|
—
|
0
|
$56.61 | -$4,340,645.00 | 22.52K |
Jun 18
| |||
Form 4
| -12.54% | -3.23K |
$104.25 | -$336,519.00 | 22.52K |
Jun 13
| |||
Form 4
| -10.03% | -2.87K |
$104.63 | -$300,497.36 | 25.75K |
Jun 10
| |||
Form 4
| +89.27% | 13.5K |
—
|
—
| 28.62K |
Feb 28
| |||
Form 4
|
—
|
0
|
$25.00 | -$953,400.00 | 15.12K |
Sep 10
| |||
Form 4
| +417.38% | 12.2K |
—
|
—
| 15.12K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +3,904.11% | 2.85K |
$17.68 | $50,388.00 | 2.92K |
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHARMACEUTICAL PRODUCT DEVELOPMENT INC No price found
Executive Vice PresidentPaul S Covington owns 881 units of Common Stock. From 2004 to 2008 Paul S Covington acquired a total of 218,593 shares in PHARMACEUTICAL PRODUCT DEVELOPMENT INC at a cost of $5,540,282.66, Paul also disposed a total of 235,371 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC equalling to $11,291,136.83.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +236.26% | 619 |
$36.33 | $22,488.27 | 881 |
Jun 30
| |||
Form 4
| -97.49% | -10.20K |
$46.95 | -$478,747.80 | 262 |
Feb 28
| |||
Form 4
| +3,891.60% | 10.2K |
$40.59 | $19,339.15 | 11.06K |
Feb 28
| |||
Form 4
|
—
|
0
|
$34.10 | -$645,578.90 | 262 |
Feb 26
| |||
Form 4
|
∞
| 262 |
$34.44 | $9,023.28 | 262 |
Dec 31
| |||
Form 4
| -100.00% | -9.04K |
$35.09 | -$317,389.05 |
0
|
Aug 29
| |||
Form 4
| +2.97% | 261 |
$29.00 | $7,569.00 | 9.04K |
Jun 30
| |||
Form 4
| -16.62% | -1.75K |
$27.16 | -$676,553.04 | 8.78K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +3.05% | 312 |
$29.00 | $9,048.00 | 10.53K |
Dec 31
| |||
Form 4
| +3.16% | 313 |
$27.87 | $8,723.31 | 10.22K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
$52.72 | -$857,792.72 | 4.95K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +1.58% | 77 |
$40.12 | $3,089.24 | 4.95K |
Dec 31
| |||
Form 4
|
—
|
0
|
$39.77 | -$1,542,266.35 | 4.88K |
Aug 23
| |||
Form 4
|
—
|
0
|
$42.88 | -$336,827.84 | 4.88K |
Aug 19 - Aug 22
| |||
Form 4
| +3.81% | 179 |
$35.10 | $6,282.90 | 4.88K |
Jun 30
| |||
Form 4
| -5.30% | -263.00 |
$31.56 | $3,534.72 | 4.7K |
Dec 28 - Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
$28.26 | -$747,853.24 | 4.96K |
Nov 12
| |||
Form 4
| +2.65% | 128 |
$22.92 | $2,933.76 | 4.96K |
Jun 30
| |||
Form 4
| -63.39% | -8.37K |
$30.07 | -$251,583.76 | 4.83K |
May 20 - May 21
| |||
Form 4/A
| +0.97% | 127 |
$22.92 | $2,910.84 | 13.2K |
Dec 31
| |||
Form 4
| +0.97% | 127 |
$22.92 | $2,910.84 | 13.2K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
| +1.88% | 241 |
$24.42 | $5,885.22 | 13.07K |
Jun 30
| |||
| No matching records found | |||||||||